Generate a tailored SOP for Dr. Paul Grootendorst. Improve your application with a focused, well-structured draft.
Paul Grootendorst examines economic issues in the pharmaceutical sector, with a particular focus on drug pricing and insurance provision for community pharmacy services. His research helps inform public policy related to pricing, reimbursement, and coverage. Grootendorst's work is premised on the assumption that actors (individuals, businesses, organizations) make decisions based on furthering their goals, such as maximizing profits. He analyzes how public policy affects the net benefits of decisions and the courses of action that actors in the pharmaceutical sector undertake, examining both intended and unintended effects. His current research investigates the economics of community pharmacies and poses essential questions regarding the funding and distribution of pharmacy services across Canada, the geographic match of pharmacies with health care needs, and the trends in pharmacist licensing and practice. He also studies pharmacare policies, particularly the feasibility of provincial coverage for expensive drugs, as well as the impact of government regulations on drug pricing strategies. Grootendorst is a recognized expert in his field and frequently contributes commentary and insights to media discussions on these topics.
University of Toronto • Toronto, ON, Canada
Teaching and conducting research in pharmaceutical economics and health services policy.
Department of Sociology